Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C23H16O6.C13H16N2O |
| Molecular Weight | 604.6485 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CCCN=C1\C=C\C2=CC=CC(O)=C2.OC(=O)C3=C(O)C(CC4=C5C=CC=CC5=CC(C(O)=O)=C4O)=C6C=CC=CC6=C3
InChI
InChIKey=CCOAINFUFGBHBA-UETGHTDLSA-N
InChI=1S/C23H16O6.C13H16N2O/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;1-15-9-3-8-14-13(15)7-6-11-4-2-5-12(16)10-11/h1-10,24-25H,11H2,(H,26,27)(H,28,29);2,4-7,10,16H,3,8-9H2,1H3/b;7-6+
DescriptionSources: http://shop.demas.it/admin/uploads/articoli/4582.pdfCurator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/7639515 | https://www.ncbi.nlm.nih.gov/pubmed/19506073 | http://parasitipedia.net/index.php?option=com_content&view=article&id=2504&Itemid=2777 | https://www.ncbi.nlm.nih.gov/pubmed/20038616
Sources: http://shop.demas.it/admin/uploads/articoli/4582.pdf
Curator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/7639515 | https://www.ncbi.nlm.nih.gov/pubmed/19506073 | http://parasitipedia.net/index.php?option=com_content&view=article&id=2504&Itemid=2777 | https://www.ncbi.nlm.nih.gov/pubmed/20038616
Oxantel is a narrow-spectrum anthelmintic effective against whipworms in dogs and cats. It is ineffective against other roundworms, flukes, tapeworms or external parasites. Oxantel acts on the nervous system of the worms as inhibitors of acetylcholinesterase. Oxantel, a cholinergic anthelmintic and fumarate reductase inhibitor, significantly inhibited biofilm formation by P. gingivalis and disrupted established biofilms at concentrations below its MIC against planktonic cells. Oxantel was more effective against P. gingivalis in biofilm than metronidazole, a commonly used antibiotic for periodontitis. When oxantel was administrated to human beings for the treatment of trichuriasis, no drug reaction or side effects were reported, and the results of hematologic, biochemical and urinary examinations didn’t reveal any significant drug-related changes.
Originator
Sources: https://www.ncbi.nlm.nih.gov/pubmed/5059028
Curator's Comment: # Pfizer Inc.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL3341583 |
|||
Target ID: Fumarate reductase (Helicobacter pylori) |
|||
Target ID: CHEMBL2492 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19506073 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | TELOPAR Approved UseOxantel is a narrow-spectrum anthelmintic effective against whipworms in dogs and cats. |
|||
| Curative | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Efficacy and safety of oxantel pamoate in school-aged children infected with Trichuris trichiura on Pemba Island, Tanzania: a parallel, randomised, controlled, dose-ranging study. | 2016-01 |
|
| Efficacy and safety of albendazole plus ivermectin, albendazole plus mebendazole, albendazole plus oxantel pamoate, and mebendazole alone against Trichuris trichiura and concomitant soil-transmitted helminth infections: a four-arm, randomised controlled trial. | 2015-03 |
|
| Treatment of multiple intestinal helminthiasis with oxantel and pyrantel. | 1978 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://shop.demas.it/admin/uploads/articoli/4582.pdf
Dog: 140 mg. One tablet per 7 kg of body weight (20 mg of oxantel per 1 kg of body weight).
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7639515
The MIC, MBC and ICs values for Oxantel determined in laboratory-adapted strain NCTC 11639 of H. pylori. MIC=0.94 mM, MBC=0.94 mM, IC50=0.31 mM, IC90=1.04 mM. For the wild-type strain UNSW 10593/5 the MIC and MBC values were 0.47 nM.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C250
Created by
admin on Mon Mar 31 17:57:36 GMT 2025 , Edited by admin on Mon Mar 31 17:57:36 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB184281
Created by
admin on Mon Mar 31 17:57:36 GMT 2025 , Edited by admin on Mon Mar 31 17:57:36 GMT 2025
|
PRIMARY | |||
|
m8291
Created by
admin on Mon Mar 31 17:57:36 GMT 2025 , Edited by admin on Mon Mar 31 17:57:36 GMT 2025
|
PRIMARY | Merck Index | ||
|
272-332-6
Created by
admin on Mon Mar 31 17:57:36 GMT 2025 , Edited by admin on Mon Mar 31 17:57:36 GMT 2025
|
PRIMARY | |||
|
759296
Created by
admin on Mon Mar 31 17:57:36 GMT 2025 , Edited by admin on Mon Mar 31 17:57:36 GMT 2025
|
PRIMARY | |||
|
5281086
Created by
admin on Mon Mar 31 17:57:36 GMT 2025 , Edited by admin on Mon Mar 31 17:57:36 GMT 2025
|
PRIMARY | |||
|
100000170410
Created by
admin on Mon Mar 31 17:57:36 GMT 2025 , Edited by admin on Mon Mar 31 17:57:36 GMT 2025
|
PRIMARY | |||
|
C037225
Created by
admin on Mon Mar 31 17:57:36 GMT 2025 , Edited by admin on Mon Mar 31 17:57:36 GMT 2025
|
PRIMARY | |||
|
68813-55-8
Created by
admin on Mon Mar 31 17:57:36 GMT 2025 , Edited by admin on Mon Mar 31 17:57:36 GMT 2025
|
PRIMARY | |||
|
1871176
Created by
admin on Mon Mar 31 17:57:36 GMT 2025 , Edited by admin on Mon Mar 31 17:57:36 GMT 2025
|
PRIMARY | |||
|
C90730
Created by
admin on Mon Mar 31 17:57:36 GMT 2025 , Edited by admin on Mon Mar 31 17:57:36 GMT 2025
|
PRIMARY | |||
|
UPY1D732T0
Created by
admin on Mon Mar 31 17:57:36 GMT 2025 , Edited by admin on Mon Mar 31 17:57:36 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD